Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Clinical trial NCT03275922 · COMPLETED
Trial details
- NCT number
- NCT03275922
- Sponsor
- Impax Laboratories, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2020-07-02
- Enrollment
- 374
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.